Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1971-7-14
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0001-5156
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
673-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4397040-Adrenergic alpha-Agonists,
pubmed-meshheading:4397040-Adrenergic beta-Agonists,
pubmed-meshheading:4397040-Hemodynamics,
pubmed-meshheading:4397040-Humans,
pubmed-meshheading:4397040-Phenethylamines,
pubmed-meshheading:4397040-Shock,
pubmed-meshheading:4397040-Sympathomimetics
|
pubmed:articleTitle |
[Alpha- and beta-stimulating drugs and oxyphenyloxyethylaminoethane hydrochloride in the treatment of shock].
|
pubmed:publicationType |
Journal Article
|